|
|
在研机构- |
|
|
|
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期- |
|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females
A Randomized, Double-Blind, Placebo-Controlled Study To Assess the Safety and Efficacy of a Novel Oral Natural Extract for the Treatment of Senile Purpura
A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.
100 项与 Nexgen Dermatologics, Inc. 相关的临床结果
0 项与 Nexgen Dermatologics, Inc. 相关的专利(医药)
100 项与 Nexgen Dermatologics, Inc. 相关的药物交易
100 项与 Nexgen Dermatologics, Inc. 相关的转化医学